NCT00034164View on ClinicalTrials.gov

Safety and Efficacy of S-8184 in Second Line Treatment of Relapsed Stage IIIB or IV Non Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG

S-8184 Paclitaxel Injectable Emulsion

Trial Locations (1)

Unknown

3 Cities

Sponsors
All Listed Sponsors
lead

Achieve Life Sciences

INDUSTRY